Literature DB >> 3176085

Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage.

A Hijdra1, J van Gijn, N J Nagelkerke, M Vermeulen, H van Crevel.   

Abstract

Using logistic regression, we analyzed the predictive value of a number of entry variables with respect to the outcome variables delayed cerebral ischemia, rebleeding, and poor outcome (death or severe disability) in patients with aneurysmal subarachnoid hemorrhage. The entry variables were clinical condition on admission (grades on the Glasgow Coma Scale, Hunt and Hess system), the amount of subarachnoid and intraventricular blood and the presence of hydrocephalus on the admission computed tomogram, and antifibrinolytic treatment with tranexamic acid. We used data from a prospectively studied population of 176 patients admitted within 72 hours after subarachnoid hemorrhage. The risk of delayed cerebral ischemia was best predicted by the amount of subarachnoid blood, intraventricular blood, and antifibrinolytic treatment irrespective of clinical condition and hydrocephalus. The site of delayed cerebral ischemia was not related to the location of the subarachnoid hemorrhage. Antifibrinolytic treatment was the only entry variable (negatively) predicting the risk of rebleeding. Death or severe disability after 3 months was best predicted by the amount of subarachnoid blood and the initial clinical condition reflected by the grade on the Glasgow Coma Scale.

Entities:  

Mesh:

Year:  1988        PMID: 3176085     DOI: 10.1161/01.str.19.10.1250

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  81 in total

1.  Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design.

Authors:  Jose I Suarez; Renee H Martin
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

2.  Predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a cardiac focus.

Authors:  Khalil Yousef; Elizabeth Crago; Chien-Wen Kuo; Michael Horowitz; Marilyn Hravnak
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

3.  Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage.

Authors:  Jan Claassen; Lawrence J Hirsch; Jennifer A Frontera; Andres Fernandez; Michael Schmidt; Gregory Kapinos; John Wittman; E Sander Connolly; Ronald G Emerson; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

4.  Early MoCA-assessed cognitive impairment after aneurysmal subarachnoid hemorrhage and relationship to 1-year functional outcome.

Authors:  George Kwok Chu Wong; Sandy Wai Lam; Adrian Wong; Vincent Mok; Deyond Siu; Karine Ngai; Wai Sang Poon
Journal:  Transl Stroke Res       Date:  2013-09-07       Impact factor: 6.829

5.  Acute endovascular treatment of ruptured aneurysms in poor-grade patients.

Authors:  M Bergui; G B Bradac
Journal:  Neuroradiology       Date:  2003-12-20       Impact factor: 2.804

6.  Cerebral inflammatory response and predictors of admission clinical grade after aneurysmal subarachnoid hemorrhage.

Authors:  Khalid A Hanafy; R Morgan Stuart; Luis Fernandez; J Michael Schmidt; Jan Claassen; Kiwon Lee; E Sander Connolly; Stephan A Mayer; Neeraj Badjatia
Journal:  J Clin Neurosci       Date:  2009-12-08       Impact factor: 1.961

7.  Implications of early versus late bilateral pulmonary infiltrates in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Andreas H Kramer; Thomas P Bleck; Aaron S Dumont; Neal F Kassell; Claire Olson; Bart Nathan
Journal:  Neurocrit Care       Date:  2008-09-23       Impact factor: 3.210

8.  Outcome of patients with aneurysmal and presumed aneurysmal bleeding. A hospital study based on 100 consecutive cases in a neurological clinic.

Authors:  H Schütz; P Krack; B Buchinger; R H Bödeker; A Laun; W Dorndorf; A Agnoli
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

9.  Elevated International Normalized Ratio Is Associated With Ruptured Aneurysms.

Authors:  Anil Can; Victor M Castro; Dmitriy Dligach; Sean Finan; Sheng Yu; Vivian Gainer; Nancy A Shadick; Guergana Savova; Shawn Murphy; Tianxi Cai; Scott T Weiss; Rose Du
Journal:  Stroke       Date:  2018-09       Impact factor: 7.914

Review 10.  Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.

Authors:  Mark Chwajol; Robert M Starke; Grace H Kim; Stephan A Mayer; E Sander Connolly
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.